Onconetix Statistics
Total Valuation
Onconetix has a market cap or net worth of $2.77 million. The enterprise value is $8.10 million.
Market Cap | 2.77M |
Enterprise Value | 8.10M |
Important Dates
The next estimated earnings date is Friday, May 10, 2024, after market close.
Earnings Date | May 10, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Onconetix has 22.32 million shares outstanding. The number of shares has increased by 39.44% in one year.
Shares Outstanding | 22.32M |
Shares Change (YoY) | +39.44% |
Shares Change (QoQ) | +8.95% |
Owned by Insiders (%) | 22.00% |
Owned by Institutions (%) | 18.63% |
Float | 21.70M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 47.31 |
Forward PS | n/a |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 138.50 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.34
Current Ratio | 0.34 |
Quick Ratio | 0.27 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -54.72 |
Financial Efficiency
Return on equity (ROE) is -400.10% and return on invested capital (ROIC) is -841.19%.
Return on Equity (ROE) | -400.10% |
Return on Assets (ROA) | -89.30% |
Return on Capital (ROIC) | -841.19% |
Revenue Per Employee | $4,872 |
Profits Per Employee | -$3.12M |
Employee Count | 12 |
Asset Turnover | 0.00 |
Inventory Turnover | n/a |
Taxes
Income Tax | -12,593 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -88.53% in the last 52 weeks. The beta is 3.38, so Onconetix's price volatility has been higher than the market average.
Beta (1Y) | 3.38 |
52-Week Price Change | -88.53% |
50-Day Moving Average | 0.17 |
200-Day Moving Average | 0.45 |
Relative Strength Index (RSI) | 26.45 |
Average Volume (30 Days) | 3,806,262 |
Short Selling Information
The latest short interest is 527,177, so 2.36% of the outstanding shares have been sold short.
Short Interest | 527,177 |
Short Previous Month | 635,626 |
Short % of Shares Out | 2.36% |
Short % of Float | 2.43% |
Short Ratio (days to cover) | 1.63 |
Income Statement
In the last 12 months, Onconetix had revenue of $58,465 and -$37.41 million in losses. Loss per share was -$2.19.
Revenue | 58,465 |
Gross Profit | -1.13M |
Operating Income | -36.03M |
Pretax Income | -37.42M |
Net Income | -37.41M |
EBITDA | -36.71M |
EBIT | -36.75M |
Loss Per Share | -$2.19 |
Balance Sheet
The company has $4.55 million in cash and $9.89 million in debt, giving a net cash position of -$5.33 million or -$0.24 per share.
Cash & Cash Equivalents | 4.55M |
Total Debt | 9.89M |
Net Cash | -5.33M |
Net Cash Per Share | -$0.24 |
Equity / Book Value | -5.60M |
Book Value Per Share | -0.25 |
Working Capital | -11.35M |
Cash Flow
In the last 12 months, operating cash flow was -$13.58 million and capital expenditures -$55,044, giving a free cash flow of -$13.64 million.
Operating Cash Flow | -13.58M |
Capital Expenditures | -55,044 |
Free Cash Flow | -13.64M |
FCF Per Share | -$0.80 |
Margins
Gross margin is -1,927.93%, with operating and profit margins of -61,634.47% and -63,986.48%.
Gross Margin | -1,927.93% |
Operating Margin | -61,634.47% |
Pretax Margin | -64,008.02% |
Profit Margin | -63,986.48% |
EBITDA Margin | -62,784.10% |
EBIT Margin | -62,859.25% |
FCF Margin | -23,323.46% |
Dividends & Yields
Onconetix does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -39.44% |
Shareholder Yield | -39.44% |
Earnings Yield | -1,352.48% |
FCF Yield | -492.99% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Onconetix has an Altman Z-Score of -2.37 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -2.37 |
Piotroski F-Score | 1 |